Respiratory Viral Infection

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Respiratory Viral Infection is an early-stage landscape with 0 programs across 1 company. The most active players are POLYSAN Scientific & Technological Pharmaceutical Company.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

70/100

Attrition Rate

30/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved

Phase 3

Phase 2

Phase 1

Preclinical

Key Players

Top Companies

POLYSAN Scientific & Technological Pharmaceutical Company

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed7 · 70%

Terminated3 · 30%

Clinical Trials

Trial Activity

10 trials

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00646152·57 enrolled

XC8 in the Treatment of Patients With Acute Respiratory Viral Infection

Completed·PPHARMENTERPRISES LLC·Phase 2/3·NCT03441373·320 enrolled

Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Completed·VValenta Pharm JSC·Phase 3·NCT05273619·250 enrolled

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Completed·VValenta Pharm JSC·Phase 2·NCT05269329·160 enrolled

Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection

Completed·MMateria Medica Holding·Phase 3·NCT04244084·240 enrolled

Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection

Completed·PPOLYSAN Scientific & Technological Pharmaceutical Company·N/A·NCT06286254·742 enrolled

Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients

Completed·WWashington University School of Medicine·Phase 1/2·NCT02351180·16 enrolled

Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY

Terminated·FFred Hutchinson Cancer Center·Phase 1·NCT04060849·10 enrolled

Zinc and Green Tea Extract for Community Respiratory Viral Infections

Terminated·UUniversity of Missouri-Columbia·Phase 2·NCT04898023·17 enrolled

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Terminated·AAlloVir·Phase 1/2·NCT04933968·17 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)